Dental Implants After Menopause: What the Jawbone Research Shows

A dental implant is not glued into the jaw. It fuses there, through a process called osseointegration, and a 1997 Framingham study of 488 postmenopausal women found roughly one extra tooth retained for every 4 additional years of estrogen use. That is a body-wide bone effect showing up, tooth by tooth, in the exact tissue an implant depends on. Below is the real research on how jawbone remodels, what happens to it when estrogen falls, and what shilajit's own bone research does and does not show about it.
What does it actually take for an implant to fuse to bone?

A tooth root is held in place by a web of tiny ligament fibers running between the root and the surrounding bone, with a small amount of give built in. A dental implant works differently. The titanium post is designed to fuse directly to bone with no ligament in between, a process Swedish researcher Per-Ingvar Branemark named osseointegration after noticing, almost by accident in the 1950s, that titanium chambers implanted in rabbit bone could not be removed without breaking the bone itself.
That fusion is not instant. For the first 6 to 12 weeks after placement, the bone at the implant surface is actively remodeling. Old bone cells clear a thin layer of tissue damaged during surgery. New bone-building cells lay fresh bone directly onto the implant's textured surface. Most protocols wait out that whole window before loading the implant with a crown.
That remodeling step is where bone quality matters most, and it is not a one-time event.
The two crews building your jaw, every single day
Your jawbone is not static scaffolding. It runs on two cell populations in constant rotation, the same pair that remodels the hip and spine:
- Osteoclasts, which clear away small amounts of old bone
- Osteoblasts, which lay down new bone to replace it
- Together, this pair keeps bone turning over your whole life, jaw included, not just during childhood growth
- Alveolar bone, the bone directly holding a tooth or implant, remodels faster than almost any other bone in the body
- That speed cuts both ways: it responds quickly to a favorable signal, and just as quickly to an unfavorable one
- An implant needs the osteoblast side of that pair doing visible, active work at the surgical site within weeks
For most of adult life, these two crews stay roughly matched, so the bone holding your teeth stays stable.
Why does jawbone loss accelerate after menopause?

Estrogen is one of the main signals keeping that osteoclast-osteoblast balance even. When estrogen falls at menopause, osteoclasts keep clearing bone at close to the same pace. Osteoblast activity slows. The clearing crew keeps working. The building crew goes quiet. That is the same mechanism behind hip and spine bone loss, in the exact tissue an implant is placed into. For a longer look at how that process plays out at the hip and spine, see Optimum's shilajit and bone research.
A few things make this a genuinely different situation for a woman considering an implant after menopause, compared to one placed years earlier:
- Alveolar bone remodels faster than almost any bone in the body, so it reacts quickly to a favorable signal and just as quickly to an unfavorable one
- Losing a tooth accelerates local bone loss at that specific site, since the bone stops receiving the mechanical loading signal chewing normally provides
- That local pressure stacks on top of the body-wide one, rather than replacing it
- Low systemic bone density has been linked to higher early implant failure rates in several published reviews
- Outcomes still vary widely, and many women with osteoporosis have implants succeed without any complication
- Jaw and hip bone are not separate systems. They answer to the same hormonal signal, on different schedules
None of this means an implant will fail. It means the bone an implant depends on is not separate from the bone losing density at the hip, a connection rarely explained before surgery.
What does the shilajit and jawbone research actually show?

Shilajit has never been tested in a human trial against implant placement, implant failure, or osseointegration. What exists is a smaller, honest body of animal and cell research, aimed at the exact bone tissue an implant depends on.
In a 2019 study, Turkish researchers gave shilajit systemically to rats undergoing rapid maxillary expansion, a jaw-widening procedure that depends on new bone filling the gap it creates. That gap is mechanically close to the healing gap around a fresh implant. New bone formation at the jaw suture scored at its strongest level in 5 of 8 shilajit-treated rats, against 1 of 8 given the procedure alone. A blood marker of bone-building activity ran significantly higher in the shilajit group too.
A 2025 cell study took a different angle. Researchers placed human periodontal ligament cells, the fiber cells that anchor a natural tooth into bone, directly into a shilajit solution. At the doses tested, the cells closed a lab-made wound faster. They migrated more actively. They switched on more of the gene that builds type I collagen, the structural protein these fibers are made of. The same researchers noted shilajit also raised two inflammatory markers at that dose, calling it a controlled inflammatory response rather than a harmful one. This article treats that finding as exactly what it is, cells in a dish, not a clinical outcome.
A related constituent of shilajit, humic acid, has its own line of rat research on jaw bone specifically:
- Calisir 2016, oral humic acid, 15 days: osteoblast activity up, osteoclast number down, alveolar bone loss down
- Lima 2024, humic acid by mouth, 28 days: less attachment loss, less bone loss, more osteocytes (the mature cells living inside formed bone)
- Tavares 2025, 80 mg/kg: less bone loss, improved redox markers above that dose
- Orlando 2025, 80 mg/kg over 28 days: lower bone loss, inflammatory markers down
- Toledo 2026, estrogen-depleted mice specifically: alveolar bone loss attenuated, a bone-protecting signal raised
Five separate research teams, five separate rat models, and every one found the same direction of effect on jaw bone.
What this research does and does not prove
- These are animal and cell studies. None of them placed a dental implant, and none of them involved a human patient recovering from implant surgery.
- The jaw suture expansion model and the periodontitis model are both real bone-loss and bone-formation challenges, but neither one is osseointegration around a titanium implant specifically.
- Shilajit's own human bone evidence comes from a different site entirely: a clinical trial in postmenopausal women with hip and spine osteoporosis, not the jaw.
What does bone-graft research tell us about healing around an implant?

When a patient's own jawbone is too thin for an implant, surgeons often pack the site with graft material first and let new bone grow around it before placing the implant. That scenario, foreign material that needs living bone to grow onto and through it, is mechanically close to what happens at an implant surface during osseointegration.
A 2025 study tested exactly that setup. Researchers gave high-dose shilajit to rats with a surgically created bone defect packed with bovine bone-graft material, the same kind of graft a dental surgeon might use. The result was stark: new bone grew across 78.1% of the defect area in the shilajit group, against 9.8% fibrous tissue filling the same space in untreated animals. A key inflammatory marker also dropped in a clear, dose-dependent pattern.
That defect was in the shin bone, not the jaw. The study does not describe the delivery method in enough detail for this article to state the route with confidence, so it is reported here as bone-graft healing research, not an oral or dietary claim.
| Study | Model | What it measured | What it found |
|---|---|---|---|
| Cesur et al., 2019 | Rat, jaw suture expansion | New bone formation, systemic shilajit | Strongest bone score in 5 of 8 shilajit rats vs 1 of 8 controls |
| Alqarni et al., 2025 | Human ligament cells, lab dish | Cell migration, collagen gene activity | Faster wound closure, higher type I collagen gene expression |
| 5-study humic acid line, 2016-2025 | Rat, periodontitis | Alveolar bone loss, osteoclast activity | Less bone loss, lower osteoclast activity across every study |
| 2025 xenograft study | Rat, shin bone defect | New bone area vs. fibrous tissue | 78.1% new bone vs. 9.8% fibrous in the shilajit group |
Two threads run through all four rows. One is osteoblast activity picking up. The other is osteoclast activity or inflammation settling down. Those are the same two crews discussed above, measured in different tissue, by different research teams, none of them studying an implant. For the human bone trial behind this same mechanism, see Optimum's full breakdown of the shilajit osteoporosis clinical trial.
What should you ask before getting an implant after menopause?
A dental implant consultation rarely covers systemic bone health unless the patient raises it first. Four questions worth bringing to that appointment:
- Whether a bone density assessment, beyond a standard dental X-ray, is appropriate before surgery
- Whether the planned implant system and healing timeline account for lower bone density, since protocols differ for exactly this reason
- Whether any active gum disease should be treated first, since the research above found humic acid's clearest effect was on bone loss already driven by periodontitis
- What the surgeon's own experience has been placing implants in women past menopause specifically, not in a general adult population
None of this replaces an in-person evaluation. It is a starting list for a conversation that, based on the research here, does not happen often enough on its own.
Common questions
Can a dental implant fail because of osteoporosis?
Low bone density is associated with a higher rate of early implant failure in several published reviews, though the research is mixed and implants succeed in many women with osteoporosis. What is well established is that osseointegration, the process of bone physically fusing to the implant, depends on having enough active, remodeling bone at the site. The jaw is not exempt from the same estrogen-driven bone turnover that affects the hip and spine.
What is osseointegration, in plain terms?
It is the process by which living bone grows directly onto and into the surface of a dental implant, locking it in place without any fibrous tissue in between. It was first described in the 1960s by Dr. Per-Ingvar Branemark, who found titanium could bond this tightly with bone, and it is the entire reason modern implants work at all.
Has shilajit been tested on dental implants specifically?
No. No human trial has tested shilajit against implant healing or osseointegration. What exists is separate, real animal and cell research: shilajit accelerating new bone formation in a rat jaw, humic acid reducing bone loss around rat teeth, and shilajit's effect on the human ligament cells that anchor a tooth root. This article lays out each finding and where the evidence stops.
Does the bone loss that affects implants happen everywhere in the jaw, or just where a tooth is missing?
Both. Losing a tooth accelerates local bone loss at that site because the bone no longer gets the mechanical signal from chewing. But the jaw also loses density as part of the same body-wide process that lowers bone density at the hip and spine after menopause, which is a separate and ongoing pressure on the bone an implant needs.
What actually improves implant success for someone already past menopause?
A thorough pre-surgical bone density assessment, choosing an implant system and loading protocol suited to lower-density bone, treating any active gum disease first, and controlling other risk factors such as smoking all have real evidence behind them. None of that is a substitute for a surgeon experienced in placing implants in older patients, and anyone considering one should raise bone health directly with that surgeon.

See Optimum Shilajit
Optimum Shilajit is built around the same bone-remodeling research discussed above, the **osteoclast and osteoblast balance** that governs bone at the hip, the spine, and the jaw alike. It has not been tested against dental implants, and this article makes no such claim. See Optimum Shilajit.
See See Optimum ShilajitSources
- Branemark PI et al. Osseointegrated titanium fixtures in the treatment of edentulousness. Biomaterials. 1983.
- Krall EA, Dawson-Hughes B, Hannan MT, et al. Postmenopausal estrogen replacement and tooth retention. Am J Med. 1997. PMID 9217668.
- Cesur MG, et al. Effects of shilajit on new bone formation during rapid maxillary expansion in rats. SDU Tip Fak Derg. 2019;26(1):96-103.
- Alqarni A, et al. Shilajit and human periodontal ligament cell behavior. BMC Complement Med Ther. 2025. PMID 40057709.
- Calisir M, et al. Effect of systemic humic acid on alveolar bone loss in experimental periodontitis. J Periodontal Res. 2016. PMID 26547279.
- Lima BRA, et al. Oral humic acid and alveolar bone loss in experimental periodontitis. 2024. PMID 39767617.
- Toledo LV, et al. Oral humic acid, calcium/phosphorus, and alveolar bone in estrogen-depleted mice. Biomedicines. 2026;14(6):1244. PMID 42351672.
- Shilajit and bone regeneration in a rat xenograft bone defect model. Life. 2025. PMID 41157202.